Search Results - "Lanagan, Catherine"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma by Stark, Mitchell S, Bonazzi, Vanessa F, Boyle, Glen M, Palmer, Jane M, Symmons, Judith, Lanagan, Catherine M, Schmidt, Christopher W, Herington, Adrian C, Ballotti, Robert, Pollock, Pamela M, Hayward, Nicholas K

    Published in Oncotarget (10-07-2015)
    “…To identify 'melanoma-specific' microRNAs (miRNAs) we used an unbiased microRNA profiling approach to comprehensively study cutaneous melanoma in relation to…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo by Oo, Zay Yar, Stevenson, Alexander J, Proctor, Martina, Daignault, Sheena M, Walpole, Sebastian, Lanagan, Catherine, Chen, James, Škalamera, Dubravka, Spoerri, Loredana, Ainger, Stephen A, Sturm, Richard A, Haass, Nikolas K, Gabrielli, Brian

    Published in Clinical cancer research (15-06-2018)
    “…Checkpoint kinase 1 inhibitors (CHEK1i) have single-agent activity and Here, we have investigated the molecular basis of this activity. We have assessed a…”
    Get full text
    Journal Article
  5. 5
  6. 6

    High efficiency ex vivo cloning of antigen-specific human effector T cells by Neller, Michelle A, Lai, Michael H-L, Lanagan, Catherine M, O'Connor, Linda E, Pritchard, Antonia L, Martinez, Nathan R, Schmidt, Christopher W

    Published in PloS one (04-11-2014)
    “…While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to…”
    Get full text
    Journal Article
  7. 7

    Dendritic cell immunotherapy for stage IV melanoma by O'Rourke, Michael G E, Johnson, Maree K, Lanagan, Catherine M, See, Janet L, O'Connor, Linda E, Slater, Gregory J, Thomas, David, Lopez, José Alejandro, Martinez, Nathan R, Ellem, Kay A O, Schmidt, Christopher W

    Published in Melanoma research (01-10-2007)
    “…Active boosting of the antitumour immune response of patients with solid malignancies has been tested in a large number of trials. Isolated complete clinical…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Melanoma mutations modify melanocyte dynamics in co-culture with keratinocytes or fibroblasts by Škalamera, Dubravka, Stevenson, Alexander J, Ehmann, Anna, Ainger, Stephen A, Lanagan, Catherine, Sturm, Richard A, Gabrielli, Brian

    Published in Journal of cell science (15-12-2019)
    “…Melanocytic cell interactions are integral to skin homeostasis, and affect the outcome of multiple diseases, including cutaneous pigmentation disorders and…”
    Get full text
    Journal Article
  10. 10

    Abstract A33: Defect in S phase cell cycle checkpoint renders tumours vulnerable to CHK1 inhibitor single-agent treatment in vitro and in vivo by Oo, Zay Yar, Stevenson, Alexander, Lanagan, Catherine, Spoerri, Loredana, Larsen, Jill, Gabrielli, Brian

    Published in Molecular cancer research (01-04-2017)
    “…Abstract CHK1 inhibitors are being investigated as chemosensitizing agents with agents that increase replication stress. Here we have investigated the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells: e110741 by Neller, Michelle A, Lai, Michael H-L, Lanagan, Catherine M, O'Connor, Linda E, Pritchard, Antonia L, Martinez, Nathan R, Schmidt, Christopher W

    Published in PloS one (01-11-2014)
    “…While cloned T cells are valuable tools for the exploration of immune responses against viruses and tumours, current cloning methods do not allow inferences to…”
    Get full text
    Journal Article